Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

NCT02901717 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Catheter-related Infections

Interventions

DRUG: Mino-Lok
DRUG: Antibiotic lock

Sponsor

Leonard-Meron Biosciences, Inc.